NeuroPointDX is a Madison-based company dedicated to improving the lives of children and families affected by autism spectrum disorder (ASD) and other neurological disorders. They provide innovative tools for earlier diagnosis and more precise treatment, utilizing their NPDX ASD blood test and unique metabolic subtyping to inform personalized interventions based on the individual's biology.
Through their extensive research and clinical studies, NeuroPointDX has validated the accuracy of their test panels, offering an overall accuracy rate of 81%. Their commitment to identifying more children with ASD and providing tailored treatment options has positioned them as a leading authority in the field, with their findings published in reputable scientific journals such as Frontiers in Psychiatry and Autism Research.
Generated from the website
